Using plasticity-promoting drugs to treat neuropsychological disorders

​Interview with David Olson

Assistant Professor David Olson leads a team of researchers exploring how hallucinogenic drugs impact the structure of neurons. Olson is the cofounder of the UC Davis enabled startup Delix Therapeutics Inc., which is investigating hallucinogenic compounds for increasing neural plasticity. ​